China court freezes $318m Nexperia assets in Wingtech dispute
Synopsis
A Chinese court has frozen US$318 million in Nexperia assets across three cities until 2029, escalating Wingtech's lawsuit — filed under China's anti-foreign sanctions law — that seeks US$1.17 billion in compensation and full control of the Dutch chipmaker's Chinese operations.
Key Takeaways
The Dongguan Intermediate People's Court in Guangdong has frozen 2.14 billion yuan (US$318 million) in Nexperia -affiliated assets.
The freeze covers equity interests in four Nexperia subsidiaries and one entity linked to Itec BV , spanning Dongguan , Shanghai , and Wuxi .
The order runs for three years , expiring in August 2029 .
Wingtech filed the underlying lawsuit in May under China 's anti-foreign sanctions law, seeking 8 billion yuan (US$1.17 billion) in damages and restoration of full control over Nexperia .
The case has not yet gone to trial; the freeze is a pre-trial protective measure.
Daily operations at the frozen entities are reportedly unaffected, according to DeHeng Law Offices partner Luo Zhiyu .
A Chinese court has frozen 2.14 billion yuan (US$318 million) in assets tied to Nexperia, the Dutch semiconductor firm, deepening a legal battle that is rapidly severing its Chinese manufacturing operations from its European headquarters. The Dongguan Intermediate People's Court in Guangdong province issued the freeze order, affecting equity interests across subsidiaries in Dongguan, Shanghai, and Wuxi, with the ruling set to remain in force until August 2029.
What the court ordered
The freeze covers equity interests in four subsidiaries owned by Nexperia, as disclosed in a Monday filing to the Shanghai Stock Exchange by Wingtech. Equity interests held by Itec BV — a chip tooling company spun off from Nexperia in 2021 — in another Chinese entity have also been frozen. The Dongguan plant is Nexperia's largest assembly and test facility in China.
Why it matters
The order is designed to "protect Chinese subsidiaries' assets from being transferred or pledged as collateral," according to Luo Zhiyu, a partner at DeHeng Law Offices in Beijing who specialises in cross-border transactions and overseas listings. He added that the daily operations of the affected entities would not be disrupted. The freeze effectively cements the operational independence of Nexperia's Chinese manufacturing engine from its Dutch parent, leaving local facilities increasingly isolated.
The Wingtech lawsuit backdrop
Wingtech filed a lawsuit against Nexperia and three of its executives in May under China's anti-foreign sanctions law, demanding the full restoration of control over Nexperia and 8 billion yuan (US$1.17 billion) in compensation. The case has not yet gone to trial. The asset freeze marks a significant escalation ahead of any formal hearing, signalling that Chinese courts are willing to deploy protective measures at scale before litigation concludes.
Competitive backdrop
Nexperia, which specialises in discrete semiconductors and logic chips, has been at the centre of geopolitical scrutiny for years, particularly over its 2021 acquisition of Newport Wafer Fab in the UK, which was later unwound under government pressure. The current dispute with Wingtech — its former Chinese parent — underscores the growing fragility of cross-border chip ownership structures as regulatory and legal environments on both sides tighten.
What's next
With the freeze locked in until August 2029 and the underlying lawsuit yet to reach trial, Nexperia's ability to restructure, divest, or leverage its Chinese assets remains severely constrained. Investors and industry observers will be watching whether Wingtech's anti-foreign sanctions claim gains traction in court — a verdict that could set a precedent for how foreign-owned chip assets in China are treated in future disputes.
Point of View
Not merely a geopolitical one — a dimension that mainstream coverage often underplays. By invoking the law to freeze assets pre-trial, Chinese courts are effectively granting domestic shareholders a structural veto over foreign parent companies in contested ownership situations. For global chipmakers with significant China manufacturing exposure, this case is a stress test of whether cross-border semiconductor ownership structures built in a more permissive era can survive today's legal climate. The three-year freeze horizon, stretching to 2029, also signals that resolution will be slow — compounding uncertainty for Nexperia's European stakeholders at a time when the broader chip industry is already navigating export controls and supply chain realignment.
NationPress
1 Sept 2026
Frequently Asked Questions
Why did a Chinese court freeze Nexperia's assets?
The Dongguan Intermediate People's Court froze 2.14 billion yuan (US$318 million) in Nexperia assets as a pre-trial protective measure in a lawsuit filed by Wingtech . The freeze is intended to prevent the assets from being transferred or pledged as collateral while litigation proceeds.
What is Wingtech demanding from Nexperia?
Wingtech is demanding full restoration of control over Nexperia and 8 billion yuan (US$1.17 billion) in compensation. The lawsuit, filed in May , invokes China 's anti-foreign sanctions law and names Nexperia and three of its executives as defendants.
How long will the Nexperia asset freeze last?
The court order is set to remain in force for three years , until August 2029 . During this period, Nexperia 's ability to restructure or leverage its frozen Chinese subsidiaries will be severely restricted.
Will Nexperia's China operations be disrupted by the freeze?
According to Luo Zhiyu , a partner at DeHeng Law Offices in Beijing , the daily operations of the affected entities will not be disrupted. The freeze targets equity interests — ownership stakes — rather than physical assets or production lines.
What is China's anti-foreign sanctions law and how does it apply here?
China 's anti-foreign sanctions law allows Chinese entities and individuals to seek legal redress when they believe they have been harmed by foreign sanctions or related measures. Wingtech has invoked this law against Nexperia , though the case has not yet gone to trial and the specific allegations remain subject to court review.
